0001415889-24-014378.txt : 20240523 0001415889-24-014378.hdr.sgml : 20240523 20240523181806 ACCESSION NUMBER: 0001415889-24-014378 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240522 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIEFLIN WILLIAM JL CENTRAL INDEX KEY: 0001182471 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 24980166 MAIL ADDRESS: STREET 1: NGM BIOPHARMACEUTICALS, INC. STREET 2: 333 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 form4-05232024_100501.xml X0508 4 2024-05-22 0001673772 RAPT Therapeutics, Inc. RAPT 0001182471 RIEFLIN WILLIAM JL C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 true false false false 0 Stock Option (right to buy) 4.63 2024-05-23 4 A 0 36490 0 A 2034-05-21 Common Stock 36490 36490 D The Option shall vest in 12 equal monthly installments from date of grant of May 22, 2024. /s/ Rodney Young, Attorney-in-Fact for William Rieflin 2024-05-23